Aetna, Inc. (AET) Tops Q3 EPS by 21c; Boosts FY12 Op. EPS Outlook to $5.10
Tweet
Share
E-mailGet Alerts AET Hot Sheet
Price: $212.70 --0%
Financial Fact:
Net realized capital gains: 34.8M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net realized capital gains: 34.8M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Aetna, Inc. (NYSE: AET) reported Q3 EPS of $1.55, $0.21 better than the analyst estimate of $1.34. Revenue for the quarter came in at $8.9 billion versus the consensus estimate of $8.96 billion.
Aetna, Inc. sees FY2012 EPS of $5.10, versus prior guidance of $5.00-5.10 and the consensus of $5.08.
For earnings history and earnings-related data on Aetna, Inc. (AET) click here.
Aetna, Inc. sees FY2012 EPS of $5.10, versus prior guidance of $5.00-5.10 and the consensus of $5.08.
For earnings history and earnings-related data on Aetna, Inc. (AET) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
- BMO starts chip stocks coverage: Here are its preferred picks
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
